BG103918A - Soluble sertraline compositions - Google Patents

Soluble sertraline compositions

Info

Publication number: BG103918A
Authority: BG; Bulgaria
Prior art keywords: compositions; soluble; soluble sertraline; sertraline compositions; sertraline
Prior art date: 1997-07-01

Application number

BG103918A

Other languages

Bulgarian (bg)

English (en)

Inventor

Dwayne T. Friesen

Scott M. Herbig

Ravi M. Shanker

James B. West

Original Assignee

Pfizer Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1999-11-23

Publication date

2000-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG103918(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-23 Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc

2000-07-31 Publication of BG103918A publication Critical patent/BG103918A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BG103918A 1997-07-01 1999-11-23 Soluble sertraline compositions BG103918A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en)	1997-07-01	1998-06-15	Solubilized sertraline compositions

Publications (1)

Publication Number	Publication Date
BG103918A true BG103918A (en)	2000-07-31

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG103918A BG103918A (en)	1997-07-01	1999-11-23	Soluble sertraline compositions

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (pt)
JP (1)	JP2000514100A (pt)
KR (1)	KR100366373B1 (pt)
CN (1)	CN1261794A (pt)
AP (1)	AP1192A (pt)
AR (3)	AR015917A1 (pt)
AU (1)	AU742535B2 (pt)
BG (1)	BG103918A (pt)
BR (1)	BR9810739A (pt)
CA (1)	CA2290974C (pt)
CO (1)	CO4940495A1 (pt)
DZ (1)	DZ2548A1 (pt)
EA (1)	EA002481B1 (pt)
HN (1)	HN1998000102A (pt)
HR (1)	HRP980377A2 (pt)
HU (1)	HUP0002236A3 (pt)
ID (1)	ID23429A (pt)
IL (1)	IL133076A (pt)
IS (1)	IS5260A (pt)
MA (1)	MA24587A1 (pt)
NO (1)	NO996520L (pt)
OA (1)	OA11243A (pt)
PA (1)	PA8454301A1 (pt)
PE (1)	PE97199A1 (pt)
PL (1)	PL337804A1 (pt)
SK (1)	SK181099A3 (pt)
TN (1)	TNSN98124A1 (pt)
TR (1)	TR199903297T2 (pt)
TW (1)	TW550087B (pt)
UA (1)	UA67741C2 (pt)
UY (1)	UY25071A1 (pt)
WO (1)	WO1999001120A1 (pt)
YU (1)	YU68299A (pt)
ZA (1)	ZA985708B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003518485A (ja)	1999-12-23	2003-06-10	ファイザー・プロダクツ・インク	向上された薬物濃度を与える医薬組成物
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
WO2002017918A2 (en)	2000-08-30	2002-03-07	Pfizer Products Inc.	Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) *	2007-03-12	2015-03-06	디에스엠 아이피 어셋츠 비.브이.	미용 조성물
EP2520299A1 (en) *	2009-12-29	2012-11-07	Kowa Co., Ltd.	Solid pharmaceutical composition for oral administration
EP2520300A4 (en) *	2009-12-29	2013-05-08	Kowa Co	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736A (zh) *	2022-05-20	2022-08-12	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
EP0415612B1 (en) *	1989-08-30	1993-11-10	Pfizer Inc.	Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active IP Right Cessation
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Application Discontinuation
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/xx active
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown

Also Published As

Publication number	Publication date
MA24587A1 (fr)	1998-12-31
UY25071A1 (es)	2000-12-29
OA11243A (en)	2003-07-24
UA67741C2 (uk)	2004-07-15
AR015917A1 (es)	2001-05-30
EP0999829A1 (en)	2000-05-17
WO1999001120A1 (en)	1999-01-14
PE97199A1 (es)	1999-10-05
IL133076A (en)	2003-12-10
HUP0002236A3 (en)	2003-12-29
EA199900962A1 (ru)	2000-08-28
CA2290974A1 (en)	1999-01-14
AU742535B2 (en)	2002-01-03
PA8454301A1 (es)	2000-09-29
TR199903297T2 (xx)	2000-07-21
PL337804A1 (en)	2000-09-11
DZ2548A1 (fr)	2003-02-08
AR040280A2 (es)	2005-03-23
JP2000514100A (ja)	2000-10-24
YU68299A (sh)	2002-06-19
ZA985708B (en)	2000-01-10
IS5260A (is)	1999-11-19
CO4940495A1 (es)	2000-07-24
BR9810739A (pt)	2000-09-12
KR20010013365A (ko)	2001-02-26
HUP0002236A2 (hu)	2003-08-28
AR040279A2 (es)	2005-03-23
CA2290974C (en)	2004-04-27
AP9801280A0 (en)	1998-06-30
TW550087B (en)	2003-09-01
SK181099A3 (en)	2000-07-11
NO996520L (no)	2000-02-29
HN1998000102A (es)	1999-01-08
IL133076A0 (en)	2001-03-19
TNSN98124A1 (fr)	2005-03-15
NO996520D0 (no)	1999-12-28
EA002481B1 (ru)	2002-06-27
AP1192A (en)	2003-07-23
KR100366373B1 (ko)	2003-01-14
ID23429A (id)	2000-04-20
HRP980377A2 (en)	1999-04-30
AU7544898A (en)	1999-01-25
CN1261794A (zh)	2000-08-02

Publication	Publication Date	Title
EP0680694A3 (en)	1996-01-10	Composition of fluorescent biocides for use in aqueous systems.
ZA966404B (en)	1998-01-26	Ultramild aqueous cleansing compositions.
MY125333A (en)	2006-07-31	Antibacterial compositions containing a solvent, hydrotrope and surfactant.
DE69716135D1 (en)	2002-11-07	In 6-position durch thio substituierte paclitaxele
NZ336348A (en)	2000-09-29	Solid block alkaline detergent composition comprising an alkalinity source, and a binding agent comprising an alkali metal carbonate mono hydrate and an organic sequestrant
HUP0103929A3 (en)	2002-08-28	Heterocyclyl amino methyloxazolidinones as antibacterials and pharmaceutical compositions containing the same
ZA989560B (en)	1999-07-02	Compositions containing an Ó 1,2-fucose linkage and uses thereof.
ZA979477B (en)	1998-06-10	Low residue aqueous hard surface cleaning and disinfecting compositions.
ZA969491B (en)	1998-05-12	Near tricritical point compositions containing a bleach and/or a disinfecting agent.
BG103930A (en)	2000-07-31	Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
HK1024632A1 (en)	2000-10-20	Novel powder compositions
GB9717905D0 (en)	1997-10-29	Lipid-containing compositions and uses thereof
NZ239879A (en)	1994-06-27	Cleansing composition comprising two amphoteric surfactants-one being an imidazolinium derivative, the other an aminoalkanoate or iminodialkanoate, and an insoluble conditioning agent
EP0608780A3 (en)	1994-11-23	Fluorosilicon compositions as release agents.
BG103918A (en)	2000-07-31	Soluble sertraline compositions
ZA949151B (en)	1995-07-29	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents.
HK1013627A1 (en)	1999-09-03	High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base
AU1887399A (en)	1999-08-16	Aqueous compositions comprising complexing agents and uses therof
WO2001010408A3 (de)	2001-09-07	Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
WO2002062304A3 (de)	2003-02-27	Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend.
BG101401A (en)	1997-12-30	Cisaspide extended release oral compositions
IL126185A0 (en)	1999-05-09	Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
HK1025784A1 (en)	2000-11-24	Water-soluble trisazo compounds and aqueous ink compositions
AU2619099A (en)	1999-08-16	Aqueous precious metal colloids and the use thereof
EP0665265A3 (de)	1995-12-06	Zusammensetzungen, enthaltend Metallpartikel im Nanometergrössenbereich.